Patents Assigned to SYNPROMICS LIMITED
  • Publication number: 20220111078
    Abstract: The present invention relates to inducible regulatory elements, promoters and vectors, especially gene therapy vectors, and methods of their use.
    Type: Application
    Filed: January 20, 2020
    Publication date: April 14, 2022
    Applicant: SYNPROMICS LIMITED
    Inventors: Michael ROBERTS, Graham WHYTESIDE, Anne BRAAE
  • Publication number: 20220009981
    Abstract: The present invention relates to regulatory nucleic acid sequences, in particular liver-specific cis-regulatory elements, cis-regulatory modules, promoters and other such nucleic acid sequences, that are capable of enhancing liver-specific expression of genes. The invention also relates to expression constructs, vectors and cells comprising such liver-specific regulatory nucleic acid sequences, and to methods of their use. The liver-specific regulatory nucleic acid sequences are of particular utility for gene therapy applications, but also find utility in other areas such as bioprocessing and biotechnology.
    Type: Application
    Filed: November 19, 2019
    Publication date: January 13, 2022
    Applicant: SYNPROMICS LIMITED
    Inventors: Michael ROBERTS, Juan Manuel IGLESIAS, Jorge Omar YANEZ-CUNA, Nicolle KIPPEN, Ross FRASER, Katie BAKER
  • Publication number: 20210388347
    Abstract: The present invention relates to regulatory nucleic acid sequences, in particular liver-specific cis-regulatory elements, cis-regulatory modules, promoters and other such nucleic acid sequences, that are capable of enhancing liver-specific expression of genes. The invention also relates to expression constructs, vectors and cells comprising such liver-specific regulatory nucleic acid sequences, and to methods of their use. The liver-specific regulatory nucleic acid sequences are of particular utility for gene therapy applications, but also find utility in other areas such as bioprocessing and biotechnology.
    Type: Application
    Filed: November 19, 2019
    Publication date: December 16, 2021
    Applicant: SYNPROMICS LIMITED
    Inventors: Juan Manuel IGLESIAS, Jorge Omar YANEZ-CUNA, Nicolle KIPPEN, Michael ROBERTS
  • Publication number: 20200199593
    Abstract: The present invention relates to the use of a regulatory nucleic acid sequences that are able to regulate gene expression in eukaryotic cells and which are responsive to the unfolded protein response (UPR). There are disclosed regulatable introns and UPR-inducible promoters, which are able to regulate gene expression. There are also disclosed recombinant expression constructs comprising such regulatory nucleic acid sequences, whereby expression of the encoded expression product can be induced by invoking the unfolded protein response (UPR) in a eukaryotic cell containing the construct, methods of using such constructs and associated vectors, cells and suchlike.
    Type: Application
    Filed: August 22, 2018
    Publication date: June 25, 2020
    Applicant: SYNPROMICS LIMITED
    Inventor: Graham WHYTESIDE